🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,88 USD

Máx. histórico

61,25

1785 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-51,22%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-2,96%

Cierre anterior

30,79

Rango de hoy

29,85 – 31,44

Volumen hoy

52.805.827

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
42,69 (puede no estar actualizado)
Dividend yield
5,59% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 13 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,76%
Fecha de pago Importe por participación
03/11/2022 0,4000 USD
28/07/2022 0,4000 USD
12/05/2022 0,4000 USD
27/01/2022 0,4000 USD
04/11/2021 0,3900 USD
29/07/2021 0,3900 USD
06/05/2021 0,3900 USD
28/01/2021 0,3900 USD
05/11/2020 0,3605 USD
30/07/2020 0,3605 USD
07/05/2020 0,3605 USD
30/01/2020 0,3605 USD
07/11/2019 0,3416 USD
01/08/2019 0,3416 USD
09/05/2019 0,3416 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/04/2023 41,29 42,22 41,17 41,55 +1,59% 2,54% 29.697.600
04/04/2023 41,44 41,53 40,76 40,90 -1,09% 1,86% 19.514.500
03/04/2023 40,69 41,47 40,65 41,35 +1,35% 2,02% 20.817.200
31/03/2023 40,55 40,83 40,28 40,80 +1,04% 1,36% 23.393.600
30/03/2023 40,42 40,49 40,25 40,38 +0,32% 0,59% 12.634.500
29/03/2023 40,16 40,27 39,99 40,25 +0,65% 0,70% 14.429.500
28/03/2023 40,20 40,30 39,86 39,99 -0,57% 1,09% 13.537.500
27/03/2023 40,54 40,62 39,97 40,22 -0,42% 1,60% 20.262.800
24/03/2023 40,09 40,46 39,87 40,39 +0,52% 1,47% 17.218.100
23/03/2023 40,17 40,50 40,00 40,18 +0,42% 1,24% 16.958.100
22/03/2023 40,70 40,85 39,99 40,01 -1,60% 2,11% 15.444.200
21/03/2023 40,86 40,91 40,31 40,66 -0,37% 1,47% 19.982.000
20/03/2023 40,14 40,86 39,94 40,81 +1,77% 2,29% 20.825.400
17/03/2023 40,63 40,79 39,99 40,10 -0,67% 1,97% 57.457.800
16/03/2023 40,06 40,49 39,72 40,37 +0,22% 1,92% 21.095.900
15/03/2023 39,76 40,53 39,46 40,28 +0,95% 2,69% 25.498.400
14/03/2023 40,05 40,15 39,52 39,90 +0,10% 1,57% 24.583.600
13/03/2023 39,26 40,51 39,26 39,86 +1,19% 3,18% 35.299.400
10/03/2023 39,29 39,93 39,23 39,39 -0,18% 1,78% 26.328.100
09/03/2023 40,41 40,57 39,31 39,46 -1,65% 3,12% 18.585.100
08/03/2023 40,32 40,57 39,91 40,12 -0,55% 1,64% 16.756.100
07/03/2023 41,06 41,13 40,10 40,34 -1,87% 2,51% 23.205.800
06/03/2023 41,09 41,26 40,82 41,11 -0,10% 1,07% 19.434.800
03/03/2023 40,91 41,18 40,74 41,15 +1,30% 1,08% 20.922.000
02/03/2023 40,06 40,78 39,81 40,62 +1,10% 2,42% 19.110.600
01/03/2023 40,56 40,76 40,14 40,18 -0,96% 1,53% 21.104.400
28/02/2023 40,50 40,71 40,09 40,57 -0,51% 1,53% 31.086.900
27/02/2023 41,44 41,73 40,73 40,78 -2,32% 2,41% 26.370.300
24/02/2023 42,03 42,05 41,51 41,75 -1,30% 1,28% 16.806.100
23/02/2023 42,29 42,75 42,22 42,30 -0,19% 1,25% 21.104.300